Technical specification for consultation on the risk of drug teratogenicity during pregnancy
Jing Tao,Xiaohong Li,Xi Tan,Li Chen,Aihua Yin,He Wang,Yangyu Zhao,Yong Yang,Xinwen Zhang,Xiaohui Zhang,Xueyan Wang,Dunjin Chen,Juan Du,Suhua Chen,Xiaoqing Jiang,Guoying Zhang,Li Li,Yan Zhang,Jinhua Gu,Fen Li,Lan Xie,Juanjuan Zhao,Chunhong Zhang,Jun Zhu
DOI: https://doi.org/10.3877/cma.j.issn.1673-5250.2021.04.004
2021-01-01
Abstract:Improper use of drugs by pregnant women during pregnancy may lead to fetal malformations. Counseling service on the risk of drug teratogenicity during pregnancy plays an important role in ensuring the safety of maternal and fetal medication and reducing birth defects. At present, some medical institutions in China have carried out counseling service on the risk of drug teratogenicity during pregnancy, but there is no relevant technical specification of the service. The Technical Specification for Consultation on the Risk of Drug Teratogenicity During Pregnancy has been jointly formulated by National Office for Maternal and Child Health Surveillance of China/National Center for Birth Defects Monitoring of China and multidisciplinary experts in department of obstetrics, pediatrics, pharmacy, etc. from Grade 3A medical institutions in China. The technical specification stipulates the definition, principle, process and service mode of drug teratogenic risk consultation service during pregnancy, in order to guide China′s medical institutions to standardize the counseling service, improve the service level, and ensure the safety of maternal and fetal medication.